Indena S.P.A.
Records under this name other than the patents Indena S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 42 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,125,925 | Abnormal intraocular pressure treatment Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,744,793 | Cosmetic compositions for protection against air pollutants Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,534,472 | Compositions Useful in the Prevention And/Or Treatment of Inflammation and Pain Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,016,478 | Combinations of Extracts of Serenoa Repens and Lipophilic Extracts of Zingiber Officinalis and Echinacea Angustifolia, the Use Thereof, and Formulations Containing Them Lapsed on the fee record Ended Jul 10, 2026 · High confidence | Lapsed on the fee record | Ended Jul 10, 2026 | High confidence |
| US 7,910,334 | Biotransformation of colchicinoid compounds Term ended Term ended Jun 27, 2026 · From the USPTO record | Term ended | Term ended Jun 27, 2026 | From the USPTO record |
| US 7,232,916 | Process for the preparation of a taxane derivative Term ended Term ended May 11, 2026 · From the USPTO record | Term ended | Term ended May 11, 2026 | From the USPTO record |
| US 7,683,163 | Colchicoside analogues Term ended Term ended Jan 9, 2026 · From the USPTO record | Term ended | Term ended Jan 9, 2026 | From the USPTO record |
| US 8,624,051 | Process for the preparation of isoserine derivatives Lapsed on the fee record Ended Jan 7, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 7, 2026 | From the USPTO record |
| US 9,839,663 | Formulations containing extracts of Echinacea angustifolia and Zingiber officinale which are useful in reducing inflammation and peripheral pain Lapsed on the fee record Ended Dec 12, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 12, 2025 | From the USPTO record |
| US 9,770,475 | Compositions for the treatment of peripheral ulcers of various origins Lapsed on the fee record Ended Sep 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 26, 2025 | From the USPTO record |